Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea
Selam Mihreteab, Lucien Platon, Araia Berhane, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 13, pp. 1191-1202
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in Africa
Tadele Emiru, Dejene Getachew, Maxwell Murphy, et al.
Nature Medicine (2023) Vol. 29, Iss. 12, pp. 3203-3211
Open Access | Times Cited: 78
Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa
Philip J. Rosenthal, Victor Asua, Melissa D. Conrad
Nature Reviews Microbiology (2024) Vol. 22, Iss. 6, pp. 373-384
Closed Access | Times Cited: 52
The emergence of artemisinin partial resistance in Africa: how do we respond?
Philip J. Rosenthal, Victor Asua, Jeffrey A. Bailey, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e591-e600
Open Access | Times Cited: 43
Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria
Kassoum Kayentao, Aissata Ongoïba, Anne C Preston, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 17, pp. 1549-1559
Open Access | Times Cited: 33
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance
Deus S. Ishengoma, Celine I. Mandara, Catherine Bakari, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 11, pp. 1225-1233
Open Access | Times Cited: 22
Emergence of Plasmodium falciparum strains with artemisinin partial resistance in East Africa and the Horn of Africa: is there a need to panic?
Ashenafi Assefa, Abebe A. Fola, Geremew Tasew
Malaria Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania
Jonathan J. Juliano, David Giesbrecht, Alfred Simkin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 27
Artemisinin-resistant malaria in Africa demands urgent action
Mehul Dhorda, Akira Kaneko, Ryuichi Komatsu, et al.
Science (2024) Vol. 385, Iss. 6706, pp. 252-254
Closed Access | Times Cited: 15
Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study
Deus S. Ishengoma, Celine I. Mandara, Catherine Bakari, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey
Jonathan J. Juliano, David Giesbrecht, Alfred Simkin, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 10, pp. 100920-100920
Open Access | Times Cited: 9
Towards next-generation treatment options to combat Plasmodium falciparum malaria
John Okombo, David A. Fidock
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 9
Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Malaria Transmission Setting in Southern Zambia
A. Martin, Jacob M. Sadler, Alfred Simkin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
High Prevalence of Molecular Markers Associated with Artemisinin, Sulphadoxine and Pyrimethamine Resistance in Northern Namibia
Lydia Eloff, Andrés Aranda-Díaz, Isobel Routledge, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Evaluation of the protective efficacy of OlysetPlus ceiling nets for reduction of malaria incidence in children in Homa Bay County, Kenya: a cluster-randomised controlled study protocol
Yura K Ko, Wataru Kagaya, Protus Omondi, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e087832-e087832
Open Access | Times Cited: 1
Treatment Failure in a UK Malaria Patient Harboring Genetically Variant Plasmodium falciparum From Uganda With Reduced In Vitro Susceptibility to Artemisinin and Lumefantrine
Donelly A. van Schalkwyk, Sade Pratt, Debbie Nolder, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 2, pp. 445-452
Open Access | Times Cited: 17
Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021
Catherine Bakari, Celine I. Mandara, Rashid A. Madebe, et al.
Malaria Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Microsatellites reveal high polymorphism and high potential for use in anti-malarial efficacy studies in areas with different transmission intensities in mainland Tanzania
Deus S. Ishengoma, Celine I. Mandara, Rashid A. Madebe, et al.
Malaria Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda
Cecile Schreidah, David Giesbrecht, Pierre Gashema, et al.
Malaria Journal (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Persistent and multiclonal malaria parasite dynamics despite extended artemether-lumefantrine treatment in children
Justin Goodwin, Richard Kajubi, Kaicheng Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda
Phyllis Awor, Romain Coppée, Nimol Khim, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 8
Closed Access | Times Cited: 5
A countrywide survey of hrp2/3 deletions and kelch13 mutation co-occurrence in Ethiopia
Claire Kamaliddin, Jack Burke-Gaffney, Shoaib Ashraf, et al.
The Journal of Infectious Diseases (2024)
Open Access | Times Cited: 5
Plasmodium falciparum ring-stage plasticity and drug resistance
Lucien Platon, Didier Ménard
Trends in Parasitology (2023) Vol. 40, Iss. 2, pp. 118-130
Open Access | Times Cited: 11
Temporal and spatial dynamics ofPlasmodium falciparumclonal lineages in Guyana
Mathieu Vanhove, Philipp Schwabl, Colette Clementson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Drug-induced stress mediates Plasmodium falciparum ring-stage growth arrest and reduces in vitro parasite susceptibility to artemisinin
Lucien Platon, Didier Leroy, David A. Fidock, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 4
Temporal and spatial dynamics of Plasmodium falciparum clonal lineages in Guyana
Mathieu Vanhove, Philipp Schwabl, Collette Clementson, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 6, pp. e1012013-e1012013
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top